Minami, Christina A.
Jin, Ginger
Freedman, Rachel A.
Schonberg, Mara A.
King, Tari A.
Mittendorf, Elizabeth A.
Funding for this research was provided by:
California Department of Public Health
National Cancer Institute
Conquer Cancer Foundation
GEMSSTAR
Centers for Disease Control and Prevention Foundation
American College of Surgeons
National Institutes of Health (5K24AG071906)
Rob and Karen Hale Distinguished Chair in Surgical Oncology
Article History
Received: 7 August 2023
Accepted: 2 October 2023
First Online: 18 October 2023
Disclosure
: Tari A. King reports speaker honoraria and compensated service on the Scientific Advisory Board of Exact Sciences. Elizabeth A. Mittendorf reports compensated service on Scientific Advisory Boards for Astra Zeneca, BioNTech and Merck; uncompensated service on Steering Committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via an SU2C grant) and Gilead. She also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. Christina A. Minami, Ginger Jin, Rachel A. Freedman, and Mara A. Schonberg report no disclosures or conflicts of interest.